Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05202834 · ClinicalTrials.gov registry record

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin

A clinical trial, sponsored by FA Corporation.

Completed
Registry status
3
Enrollment target

NCT05202834 is a clinical trial that has completed, run by FA Corporation. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05202834 has completed, sponsored by FA Corporation.

COMPLETED
Registry status
3 participants
Enrollment target

Study Summary

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin

Interventions

  • DEVICE UltraClear

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2021-07-15
Est. Completion 2021-11-10

Sponsor

FA Corporation

2 total trials

What the Registry Record Tells You About NCT05202834

The ClinicalTrials.gov registry entry for NCT05202834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FA Corporation, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which UltraClear is the first listed.

NCT05202834 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05202834 about?

NCT05202834 is a clinical study titled "Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin". Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin

What is the current status of trial NCT05202834?

This trial is currently completed. The enrollment target is 3 participants. The study started on 2021-07-15. Estimated completion is 2021-11-10.

What interventions are being tested in trial NCT05202834?

The interventions under investigation include: UltraClear (DEVICE).

Who is sponsoring clinical trial NCT05202834?

This trial is sponsored by FA Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.